{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:00:14Z","timestamp":1792598414649,"version":"4.5.0"},"reference-count":47,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2021.0254","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T08:29:04Z","timestamp":1631694544000},"source":"Crossref","is-referenced-by-count":47,"title":["Coronary In-Stent Restenosis: Predictors and Treatment"],"prefix":"10.3238","author":[{"given":"Helen","family":"Ullrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"10.3238\/arztebl.m2021.0254_ref1","doi-asserted-by":"crossref","unstructured":"Lee MS, Banka G: In-stent restenosis. Interv Cardiol Clin 2016; 5: 211\u201320","DOI":"10.1016\/j.iccl.2015.12.006"},{"key":"10.3238\/arztebl.m2021.0254_ref2","doi-asserted-by":"crossref","unstructured":"Stone GW, Ellis SG, Cox DA, et al.: One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004; 109: 1942\u20137","DOI":"10.1161\/01.CIR.0000127110.49192.72"},{"key":"10.3238\/arztebl.m2021.0254_ref3","doi-asserted-by":"crossref","unstructured":"Kuntz RE, Baim DS: Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 1993; 88: 1310\u201323","DOI":"10.1161\/01.CIR.88.3.1310"},{"key":"10.3238\/arztebl.m2021.0254_ref4","doi-asserted-by":"crossref","unstructured":"Byrne RA, Joner M, Kastrati A: Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014. Eur Heart J 2015; 36: 3320\u201331","DOI":"10.1093\/eurheartj\/ehv511"},{"key":"10.3238\/arztebl.m2021.0254_ref5","doi-asserted-by":"crossref","unstructured":"Sch\u00fchlen H, Kastrati A, Mehilli J, et al.: Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004; 147: 317\u201322","DOI":"10.1016\/j.ahj.2003.10.002"},{"key":"10.3238\/arztebl.m2021.0254_ref6","doi-asserted-by":"crossref","unstructured":"Magalhaes MA, Minha S, Chen F, et al.: Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations. Circ Cardiovasc Interv 2014; 7: 768\u201376","DOI":"10.1161\/CIRCINTERVENTIONS.114.001341"},{"key":"10.3238\/arztebl.m2021.0254_ref7","doi-asserted-by":"crossref","unstructured":"Buchanan KD, Torguson R, Rogers T, et al.: In-stent restenosis of drug-eluting stents compared with a matched group of patients with de novo coronary artery stenosis. Am J Cardiol 2018; 121: 1512\u20138","DOI":"10.1016\/j.amjcard.2018.02.033"},{"key":"10.3238\/arztebl.m2021.0254_ref8","doi-asserted-by":"crossref","unstructured":"Shlofmitz E, Iantorno M, Waksman R: Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv 2019; 12: e007023","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023"},{"key":"10.3238\/arztebl.m2021.0254_ref9","doi-asserted-by":"crossref","unstructured":"Fanelli C, Aronoff R: Restenosis following coronary angioplasty. Am Heart J 1990; 119: 357\u201368","DOI":"10.1016\/S0002-8703(05)80028-6"},{"key":"10.3238\/arztebl.m2021.0254_ref10","doi-asserted-by":"crossref","unstructured":"Gori T: Vascular wall reactions to coronary stents\u2013clinical implications for stent failure. Life (Basel) 2021; 11: 63","DOI":"10.3390\/life11010063"},{"key":"10.3238\/arztebl.m2021.0254_ref11","doi-asserted-by":"crossref","unstructured":"Gori T: Endothelial function: a short guide for the interventional cardiologist. Int J Mol Sci 2018; 19: 3838","DOI":"10.3390\/ijms19123838"},{"key":"10.3238\/arztebl.m2021.0254_ref12","doi-asserted-by":"crossref","unstructured":"Stefanini GG, Holmes DR, Jr.: Drug-eluting coronary-artery stents. N Engl J Med 2013; 368: 254\u201365","DOI":"10.1056\/NEJMra1210816"},{"key":"10.3238\/arztebl.m2021.0254_ref13","doi-asserted-by":"crossref","unstructured":"Mehran R, Dangas G, Abizaid AS, et al.: Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872\u20138","DOI":"10.1161\/01.CIR.100.18.1872"},{"key":"10.3238\/arztebl.m2021.0254_ref14","doi-asserted-by":"crossref","unstructured":"Piccolo R, Stefanini GG, Franzone A, et al.: Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis. Circ Cardiovasc Interv 2015; 8","DOI":"10.1161\/CIRCINTERVENTIONS.114.002223"},{"key":"10.3238\/arztebl.m2021.0254_ref15","doi-asserted-by":"crossref","unstructured":"Kastrati A, Schomig A, Dietz R, Neumann FJ, Richardt G: Time course of restenosis during the first year after emergency coronary stenting. Circulation 1993; 87: 1498\u2013505","DOI":"10.1161\/01.CIR.87.5.1498"},{"key":"10.3238\/arztebl.m2021.0254_ref16","doi-asserted-by":"crossref","unstructured":"Raber L, Wohlwend L, Wigger M, et al.: Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation 2011; 123: 2819\u201328","DOI":"10.1161\/CIRCULATIONAHA.110.004762"},{"key":"10.3238\/arztebl.m2021.0254_ref17","doi-asserted-by":"crossref","unstructured":"Cassese S, Byrne RA, Tada T, et al.: Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 2014; 100: 153\u20139","DOI":"10.1136\/heartjnl-2013-304933"},{"key":"10.3238\/arztebl.m2021.0254_ref18","doi-asserted-by":"crossref","unstructured":"Kastrati A, Dibra A, Mehilli J, et al.: Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 2006; 113: 2293\u2013300","DOI":"10.1161\/CIRCULATIONAHA.105.601823"},{"key":"10.3238\/arztebl.m2021.0254_ref19","doi-asserted-by":"crossref","unstructured":"Lee SY, Hong MK, Jang Y: Formation and transformation of neointima after drug-eluting stent implantation: insights from optical coherence tomographic studies. Korean Circ J 2017; 47: 823\u201332","DOI":"10.4070\/kcj.2017.0157"},{"key":"10.3238\/arztebl.m2021.0254_ref20","doi-asserted-by":"crossref","unstructured":"Pache J, Kastrati A, Mehilli J, et al.: Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003; 41: 1283\u20138","DOI":"10.1016\/S0735-1097(03)00119-0"},{"key":"10.3238\/arztebl.m2021.0254_ref21","doi-asserted-by":"crossref","unstructured":"Singh M, Gersh BJ, McClelland RL, et al.: Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation 2004; 109: 2727\u201331","DOI":"10.1161\/01.CIR.0000131898.18849.65"},{"key":"10.3238\/arztebl.m2021.0254_ref22","doi-asserted-by":"crossref","unstructured":"Raber L, Mintz GS, Koskinas KC, et al.: Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 2018; 39: 3281\u2013300","DOI":"10.1093\/eurheartj\/ehy285"},{"key":"10.3238\/arztebl.m2021.0254_ref23","doi-asserted-by":"crossref","unstructured":"Borovac JA, D\u2018Amario D, Vergallo R, et al.: Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother 2019; 5: 105\u201316","DOI":"10.1093\/ehjcvp\/pvy036"},{"key":"10.3238\/arztebl.m2021.0254_ref24","doi-asserted-by":"crossref","unstructured":"de Jaegere P, Mudra H, Figulla H, et al.: Intravascular ultrasound-guided optimized stent deployment. Immediate and 6\u00a0months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 1998; 19: 1214\u201323","DOI":"10.1053\/euhj.1998.1012"},{"key":"10.3238\/arztebl.m2021.0254_ref25","doi-asserted-by":"crossref","unstructured":"Hong MK, Mintz GS, Lee CW, et al.: Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 1305\u201310","DOI":"10.1093\/eurheartj\/ehi882"},{"key":"10.3238\/arztebl.m2021.0254_ref26","doi-asserted-by":"crossref","unstructured":"Bourassa MG, Lesperance J, Eastwood C, et al.: Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991; 18: 368\u201376","DOI":"10.1016\/0735-1097(91)90588-Z"},{"key":"10.3238\/arztebl.m2021.0254_ref27","doi-asserted-by":"crossref","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, et al.: 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87\u2013165","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"10.3238\/arztebl.m2021.0254_ref28","doi-asserted-by":"crossref","unstructured":"Maehara A, Matsumura M, Ali ZA, Mintz GS, Stone GW: IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal. JACC Cardiovasc Imaging 2017; 10: 1487\u2013503","DOI":"10.1016\/j.jcmg.2017.09.008"},{"key":"10.3238\/arztebl.m2021.0254_ref29","doi-asserted-by":"crossref","unstructured":"Nerlekar N, Cheshire CJ, Verma KP, et al.: Intravascular ultrasound guidance improves clinical outcomes during implantation of both first- and second-generation drug-eluting stents: a meta-analysis. EuroIntervention 2017; 12: 1632\u201342","DOI":"10.4244\/EIJ-D-16-00769"},{"key":"10.3238\/arztebl.m2021.0254_ref30","doi-asserted-by":"crossref","unstructured":"Jones DA, Rathod KS, Koganti S, et al.: Angiography alone versus angiography plus optical coherence tomography to guide percutaneous coronary intervention: outcomes from the Pan-London PCI Cohort. JACC Cardiovasc Interv 2018; 11: 1313\u201321","DOI":"10.1016\/j.jcin.2018.01.274"},{"key":"10.3238\/arztebl.m2021.0254_ref31","doi-asserted-by":"crossref","unstructured":"Siontis GC, Stefanini GG, Mavridis D, et al.: Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet 2015; 386: 655\u201364","DOI":"10.1016\/S0140-6736(15)60657-2"},{"key":"10.3238\/arztebl.m2021.0254_ref32","doi-asserted-by":"crossref","unstructured":"Alfonso F, Perez-Vizcayno MJ, Cuesta J, et al.: 3-year clinical follow-up of the RIBS IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents. JACC Cardiovasc Interv 2018; 11: 981\u201391","DOI":"10.1016\/j.jcin.2017.11.032"},{"key":"10.3238\/arztebl.m2021.0254_ref33","doi-asserted-by":"crossref","unstructured":"Alfonso F, P\u00e9rez-Vizcayno MJ, C\u00e1rdenas A, et al.: A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial. J Am Coll Cardiol 2015; 66: 23\u201333","DOI":"10.1016\/j.jacc.2015.04.063"},{"key":"10.3238\/arztebl.m2021.0254_ref34","doi-asserted-by":"crossref","unstructured":"Alfonso F, P\u00e9rez-Vizcayno MJ, C\u00e1rdenas A, et al.: A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V clinical trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). J Am Coll Cardiol 2014; 63: 1378\u201386","DOI":"10.1016\/j.jacc.2013.12.006"},{"key":"10.3238\/arztebl.m2021.0254_ref35","doi-asserted-by":"crossref","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D: Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2018; 7: e011245","DOI":"10.1161\/JAHA.118.011245"},{"key":"10.3238\/arztebl.m2021.0254_ref36","doi-asserted-by":"crossref","unstructured":"Alfonso F, Byrne RA, Rivero F, Kastrati A: Current treatment of in-stent restenosis. J Am Coll Cardiol 2014; 63: 2659\u201373","DOI":"10.1016\/j.jacc.2014.02.545"},{"key":"10.3238\/arztebl.m2021.0254_ref37","doi-asserted-by":"crossref","unstructured":"Moustapha A, Assali AR, Sdringola S, et al.: Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis. Catheter Cardiovasc Interv 2002; 56: 184\u20137","DOI":"10.1002\/ccd.10166"},{"key":"10.3238\/arztebl.m2021.0254_ref38","doi-asserted-by":"crossref","unstructured":"Kufner S, Hausleiter J, Ndrepepa G, et al.: Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis. JACC Cardiovasc Interv 2009; 2: 1142\u20138","DOI":"10.1016\/j.jcin.2009.08.015"},{"key":"10.3238\/arztebl.m2021.0254_ref39","doi-asserted-by":"crossref","unstructured":"Xu B, Qian J, Ge J, et al.: Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: a prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Catheter Cardiovasc Interv 2016; 87 Suppl 1: 624\u20139","DOI":"10.1002\/ccd.26401"},{"key":"10.3238\/arztebl.m2021.0254_ref40","doi-asserted-by":"crossref","unstructured":"Torrado J, Buckley L, Dur\u00e1n A, et al.: Restenosis, stent thrombosis, and bleeding complications: navigating between Scylla and Charybdis. J Am Coll Cardiol 2018; 71: 1676\u201395","DOI":"10.1016\/j.jacc.2018.02.023"},{"key":"10.3238\/arztebl.m2021.0254_ref41","unstructured":"MedMarket Diligence, LLC: Global dynamics of surgical and interventional cardiovascular procedures, 2015\u20132022. (Report #C500). MedMarket Diligence 2016."},{"key":"10.3238\/arztebl.m2021.0254_ref42","doi-asserted-by":"crossref","unstructured":"Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L: Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701\u20136","DOI":"10.1056\/NEJM198703193161201"},{"key":"10.3238\/arztebl.m2021.0254_ref43","doi-asserted-by":"crossref","unstructured":"Serruys PW, Strauss BH, Beatt KJ, et al.: Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991; 324: 13\u20137","DOI":"10.1056\/NEJM199101033240103"},{"key":"10.3238\/arztebl.m2021.0254_ref44","doi-asserted-by":"crossref","unstructured":"Stefanini GG, Taniwaki M, Windecker S: Coronary stents: novel developments. Heart 2014; 100: 1051\u201361","DOI":"10.1136\/heartjnl-2012-303522"},{"key":"10.3238\/arztebl.m2021.0254_ref45","doi-asserted-by":"crossref","unstructured":"Stettler C, Wandel S, Allemann S, et al.: Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937\u201348","DOI":"10.1016\/S0140-6736(07)61444-5"},{"key":"10.3238\/arztebl.m2021.0254_ref46","doi-asserted-by":"crossref","unstructured":"Ullrich H, M\u00fcnzel T, Gori T: Coronary stent thrombosis\u2014predictors and prevention. Dtsch Arztebl Int 2020; 117: 320\u20136","DOI":"10.3238\/arztebl.2020.0320"},{"key":"10.3238\/arztebl.m2021.0254_ref47","doi-asserted-by":"crossref","unstructured":"Elezi S, Dibra A, Mehilli J, et al.: Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. J Am Coll Cardiol 2006; 48: 1304\u20139","DOI":"10.1016\/j.jacc.2006.05.068"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T10:08:50Z","timestamp":1638785330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2021.0254","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}